Axa’s Inogen INGN Stock Holding History

Axa’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-66,900	Closed	-$773K	–	1109
2023 Q2	$773K	Buy	+66,900	New	+$788K	﹤0.01%	884
2018 Q4	–	Sell	-6,500	Closed	-$1.59M	–	1333
2018 Q3	$1.59M	Buy	+6,500	New	+$1.5M	0.01%	929

Other funds holding INGN

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

MIM

Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return

Axa's INGN Position: Q3 2023 in Review

Axa sold out of Inogen (INGN) in Q3 2023, closing a stake of 66,900 shares — an estimated $773K sold.

Axa first reported a position in INGN in Q3 2018 and held it in 2 quarters. The position peaked at $1.59M in Q3 2018. 128 funds tracked by Wall St. Rank hold INGN as of Q3 2023.

Axa reported no remaining Inogen position as of Q3 2023 after selling out during the quarter.
Axa sold 66,900 Inogen shares in Q3 2023, an estimated $773K.
Axa first reported a position in Inogen in Q3 2018 and held it in 2 quarters.
Axa's Inogen position peaked at $1.59M in Q3 2018.
128 funds tracked by Wall St. Rank held Inogen as of Q3 2023.

Based on Axa's 13F filing for Q3 2023, filed 14 Nov 2023.